Tumor Suppressor Function of Smad4 by Ubiquitin

泛素对 Smad4 的抑癌作用

• 批准号: 7437403
• 负责人: XIN-HUA FENG
• 金额: $ 22.48万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-07-01 至 2009-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7437403
• 关键词: Affinity; Area; Biological Process; Biology; Cancerous; Cell Cycle Regulation; Cell Proliferation; Cell Proliferation Regulation; Cells; Development; Disease; Disruption; Foundations; Gene Silencing; Genes; Genetic Transcription; Growth; Growth Factor; Human; Investigation; Knowledge; Lead; MADH4 gene; Malignant - descriptor; Malignant Neoplasms; Mediating; Mediator of activation protein; Modification; Molecular; Normal Cell; Organ; Outcome; Pathway interactions; Physiological; Play; Post-Translational Regulation; Principal Investigator; Proteins; Proteolysis; Regulation; Research Personnel; Research Project Grants; Role; SKP2 gene; Signal Pathway; Signal Transduction; Skp2 Proteins; Sumoylation Pathway; Testing; Tissues; Transducers; Transforming Growth Factor beta; Tumor Suppression; Tumor Suppressor Proteins; Ubiquitin; Ubiquitin Like Proteins; Ubiquitination; Work; base; cancer cell; cell growth; cell growth regulation; design; disorder prevention; human disease; insight; multicatalytic endopeptidase complex; mutant; novel; novel therapeutics; programs; receptor; response; theories; tumor; tumor progression; tumorigenesis

DESCRIPTION (provided by applicant): Loss of the antiproliferative responsiveness to TGF-beta is often considered as a major step in tumor progression. The long-term objective of this application is to understand the molecular basis of how alterations in TGF-beta antiproliferative signaling pathways lead to deregulation of growth control in human diseases. The general strategy of this application is to focus on the ubiquitin and SUMO-1 modifications of tumor suppressor SMAD4 and the physiological functions of these modifications in the regulation of cell growth and tumorigenesis. SMAD4 is a tumor suppressor. It is an essential common mediator for all the SMAD-dependent responses, thus playing a central role in signaling of TGF-beta superfamily. SMAD4 inhibits cell proliferation through transcription-dependent mechanisms. However, the mechanism of how SMAD4 is regulated remains to be elucidated. The unifying hypothesis of this proposal is that the biological functions of SMAD4 are controlled by ubiquitin/proteasome pathway and SUMOylation pathway. To test this hypothesis, we will study the molecular mechanisms of SMAD4 ubiquitination and SUMOylation, their functions in the regulation of TGF-beta signaling, and the physiological outcomes in cell growth regulation in normal and cancer cells. Four Specific Aims are proposed: 1. Determine the molecular mechanisms for SMAD4-SKP2 interaction, SMAD4 ubiquitination and proteasome-mediated degradation. 2. Examine the effects of SKP2 gene silencing on SMAD4 stability and TGF-beta antiproliferative responses. 3. Investigate the opposing functions of SKP2 and SMAD4 in human cancers. 4. Understand the inter-relationship among ubiquitination, SUMOylation and stability of SMAD4 in human cancers. The proposed studies should help to establish a working theory for the posttranslational regulation of SMAD4 activity during TGF-beta-mediated cell growth control and development, and to understand the mechanisms of SMAD4 actions in malignant transformation and progression of human cancers. Finally, the results may provide a foundation for the rational design of novel therapeutic approaches for disease prevention and treatment.

描述（由申请人提供）：对TGF-β的抗增殖反应能力的丧失通常被认为是肿瘤进展的主要步骤。该应用的长期目的是了解TGF-β抗增殖信号通路的变化如何导致人类疾病中生长控制的放松管制的分子基础。该应用的一般策略是关注肿瘤抑制剂SMAD4的泛素和SUMO-1修饰，以及这些修饰在细胞生长和肿瘤发生的调节中的生理功能。 SMAD4是肿瘤抑制剂。它是所有依赖SMAD依赖性反应的必不可少的常见介体，因此在TGF-Beta超家族的信号中起着核心作用。 SMAD4通过转录依赖性机制抑制细胞增殖。但是，如何调节SMAD4的机制尚待阐明。该提议的统一假设是SMAD4的生物学功能由泛素/蛋白酶体途径和sumoylation途径控制。为了检验这一假设，我们将研究SMAD4泛素化和Sumoylation的分子机制，它们在TGF-BETA信号调节中的功能以及正常和癌细胞中细胞生长调节的生理结果。提出了四个具体目标：1。确定SMAD4-SKP2相互作用，SMAD4泛素化和蛋白酶体介导的降解的分子机制。 2。检查SKP2基因沉默对SMAD4稳定性和TGF-β抗增殖反应的影响。 3。研究人类癌症中SKP2和SMAD4的相对功能。 4。了解人类癌症中SMAD4的泛素化，Sumoylation和稳定性之间的关系。拟议的研究应有助于建立在TGF-beta介导的细胞生长控制和发育过程中对SMAD4活性的翻译后调节的工作理论，并了解SMAD4作用在人类癌症的恶性转化和进展中的机制。最后，结果可能为预防疾病和治疗的新型治疗方法的合理设计提供了基础。